Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Chronic stress is associated with hormonal changes that are known to affect multiple systems, including the immune and endocrine systems, but the effects of stress on cancer growth and progression are not fully understood. Here, we demonstrate that human ovarian cancer cells exposed to either norepinephrine or epinephrine exhibit lower levels of anoikis, the process by which cells enter apoptosis when separated from ECM and neighboring cells. In an orthotopic mouse model of human ovarian cancer, restraint stress and the associated increases in norepinephrine and epinephrine protected the tumor cells from anoikis and promoted their growth by activating focal adhesion kinase (FAK). These effects involved phosphorylation of FAKY397, which was itself associated with actin-dependent Src interaction with membrane-associated FAK. Importantly, in human ovarian cancer patients, behavioral states related to greater adrenergic activity were associated with higher levels of pFAKY397, which was in turn linked to substantially accelerated mortality. These data suggest that FAK modulation by stress hormones, especially norepinephrine and epinephrine, can contribute to tumor progression in patients with ovarian cancer and may point to potential new therapeutic targets for cancer management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.619 · Cited by 3,254
Stress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.
Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., & Parsons, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5192 · Cited by 1,444
Self-citationChronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citationFrisch, S. M., & Screaton, R. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00251-9 · Cited by 1,249
Signaling through focal adhesion kinase
Schlaepfer, D. D., Hauck, C. R., & Sieg, D. J. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00052-2 · Cited by 1,175
Control of adhesion-dependent cell survival by focal adhesion kinase.
Frisch, S. M., Vuori, K., Ruoslahti, E., & Chan-Hui, P. Y. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.3.793 · Cited by 1,109
McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027
Research works printed but not linked: 6
- Riley, 1979, Cancer Detect Prev., 2, 235
- Lutgendorf, 2003, Clin Cancer Res., 9, 4514
- Han, 2002, Acta Pharmacol Sin., 23, 490
- 10.1037/0278-6133.4.5.403 · doi:10.1037/0278-6133.4.5.403
- Wu, 1999, Oncol Res., 11, 461
- McCarty, 1985, Arch Pathol Lab Med., 109, 716
Cited by
FAK in cancer: mechanistic findings and clinical applications
Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381
“1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo.”
BackgroundKim, S.-H., Turnbull, J., & Guimond, S. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0377 · Cited by 1,166
“Stress hormones such as norepinephrine and epinephrine can contribute to ovarian cancer progression by activating FAK, which protects the cancer cells from anoikis (Sood et al. 2010).”
BackgroundMolecular Pathways: Beta-Adrenergic Signaling in Cancer
Cole, S. W., & Sood, A. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0641 · Cited by 681
“tance to anoikis apoptosis (37), and BAD-mediated resistance to chemotherapy-induced apoptosis (16, 38).”
BackgroundSelf-citationSympathetic nervous system regulation of the tumour microenvironment
Cole, S. W., Nagaraja, A. S., Lutgendorf, S. K., Green, P. A., & Sood, A. K. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3978 · Cited by 576
Self-citationBeta Blockers and Breast Cancer Mortality: A Population- Based Study
Barron, T. I., Connolly, R. M., Sharp, L., Bennett, K., & Visvanathan, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5422 · Cited by 529
Impact of Stress on Cancer Metastasis
Moreno-Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 510
Self-citationExploiting the critical perioperative period to improve long-term cancer outcomes
Horowitz, M., Neeman, E., Sharon, E., & Ben-Eliyahu, S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.224 · Cited by 487
FAK signaling in human cancer as a target for therapeutics
Lee, B. Y., Timpson, P., Horvath, L. G., & Daly, R. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.001 · Cited by 425
Depression in cancer: The many biobehavioral pathways driving tumor progression
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M., Morris, G., Kubera, M., Köhler, C. A., Fernandes, B. S., Stubbs, B., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.004 · Cited by 375
“Moreover, stress promotes tumor cells resistance to programmed cell death in the proinflammatory tumor microenvironment [117].”
BackgroundStress and cancer: mechanisms, significance and future directions
Eckerling, A., Ricon-Becker, I., Sorski, L., Sandbank, E., & Ben-Eliyahu, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00395-5 · Cited by 348
Peng, Y.-F., Shi, Y.-H., Ding, Z.-B., Ke, A.-W., Gu, C.-Y., Hui, B., Zhou, J., Qiu, S.-J., Dai, Z., & Fan, J. (2013) · Autophagy · doi:10.4161/auto.26398 · Cited by 295
Cui, B., Luo, Y., Tian, P., Peng, F., Lu, J., Yang, Y., Su, Q., Liu, B., Yu, J., Luo, X., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121685 · Cited by 308
“Stress-induced hormones, especially norepinephrine and epinephrine, protected the ovarian tumor cells from anoikis and promoted their proliferation by phosphorylating focal adhesion kinase (FAK) at Y397 in vitro and in vivo (36).”
Mechanosensitivity and compositional dynamics of cell–matrix adhesions
Schiller, H. B., & Fässler, R. (2013) · EMBO reports · doi:10.1038/embor.2013.49 · Cited by 272
“Indeed, many kinases and adaptor proteins recruited to cell–matrix adhesions such as Src [22], Fak [23,24], p130Cas [25], c-Cbl [26], caveolin 1 and Mechanosensitivity and compositional dynamics of cell–matrix adhesions”
InfluentialNeural Regulation of Hematopoiesis, Inflammation, and Cancer
Hanoun, M., Maryanovich, M., Arnal-Estapé, A., & Frenette, P. S. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.026 · Cited by 265
“At the same time, adrenergic signals protect tumor cells from programmed cell death in both prostate and ovarian cancers (Hassan et al., 2013; Sood et al., 2010).”
Neural plasticity in pancreatitis and pancreatic cancer
Demir, I. E., Friess, H., & Ceyhan, G. O. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.166 · Cited by 255
Infante, J. R., Camidge, D. R., Mileshkin, L. R., Chen, E. X., Hicks, R. J., Rischin, D., Fingert, H., Pierce, K. J., Xu, H., Roberts, W. G., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.9346 · Cited by 242
Neeman, E., & Ben-Eliyahu, S. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.03.006 · Cited by 244
“…demonstrate that activation of tumor b-adrenoceptors can promote malignant progression by facilitating tumor survival, angiogenesis, migration, proliferation, and resistance to anoikis (Antoni et al., 2006; Bernabe et al., 2011; Sood et al., 2010, 2006; Thaker et al., 2006; Wong et al., 2011).”
BackgroundSocial isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients
Lutgendorf, S. K., DeGeest, K., Dahmoush, L., Farley, D., Penedo, F., Bender, D., Goodheart, M., Buekers, T. E., Mendez, L., Krueger, G., et al. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.012 · Cited by 242
“Catecholamines were also observed to protect tumor cells from anoikis by activating focal adhesion kinase (FAK), a protein tyrosine kinase that mediates physical attachment of cells to their ECM (Sood et al., 2010).”
BackgroundInfluentialSelf-citationNeurotransmitters: emerging targets in cancer
Jiang, S.-H., Hu, L.-P., Wang, X., Li, J., & Zhang, Z.-G. (2020) · Oncogene · doi:10.1038/s41388-019-1006-0 · Cited by 232
Behavioral stress accelerates prostate cancer development in mice
Hassan, S., Karpova, Y., Baiz, D., Yancey, D., Pullikuth, A., Flores, A., Register, T., Cline, J. M., D’Agostino, R., Danial, N., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63324 · Cited by 229
“Together with recent reports on stress-induced VEGF and IL-8 secretion (16, 55), activation of FAK (56), and downregulation of p53 (57, 58) that stimulate tumor angiogenesis, migration, invasion, and survival (26), our data highlight the connection between activation of the ADRB2/PKA axis and tumor-promoting effects o…”
Eke, I., Deuse, Y., Hehlgans, S., Gurtner, K., Krause, M., Baumann, M., Shevchenko, A., Sandfort, V., & Cordes, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61350 · Cited by 219
“One of these essential mediators of integrin signals is focal adhesion kinase (FAK), which functions in cell motility, proliferation, and the cellular stress response to ionizing radiation and chemotherapy (25–27).”
Biobehavioral Factors and Cancer Progression: Physiological Pathways and Mechanisms
Lutgendorf, S. K., & Sood, A. K. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318235be76 · Cited by 207
“Furthermore, phosphorylated FAK was linked to poorer overall survival in these patients (74).”
BackgroundSelf-citationSrc activation by β-adrenoreceptors is a key switch for tumour metastasis
Armaiz-Pena, G. N., Allen, J. K., Cruz, A., Stone, R. L., Nick, A. M., Lin, Y. G., Han, L. Y., Mangala, L. S., Villares, G. J., Vivas-Mejia, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms2413 · Cited by 212
Self-citationWatkins, J. L., Thaker, P. H., Nick, A. M., Ramondetta, L. M., Kumar, S., Urbauer, D. L., Matsuo, K., Squires, K. C., Coleman, R. L., Lutgendorf, S. K., et al. (2015) · Cancer · doi:10.1002/cncr.29392 · Cited by 196
“In vitro studies have shown that it is specifically ADRB2 stimulation that contributes to ovarian cancer development and metastasis.(2-4,13) This is supported by the improvements in OS noted among patients receiving NSBB compared with those taking any betablocker.”
BackgroundSelf-citationEng, J. W.-L., Kokolus, K. M., Reed, C. B., Hylander, B. L., Ma, W. W., & Repasky, E. A. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1617-9 · Cited by 189
“Later studies revealed that Src kinase activates a complex network of molecular signals, which ultimately foster a metastatic phenotype in ovarian cancer [54].”
BackgroundBiobehavioral approaches to cancer progression and survival: Mechanisms and interventions.
Lutgendorf, S. K., & Andersen, B. L. (2015) · American Psychologist · doi:10.1037/a0035730 · Cited by 187
“…e pe rs on al us e of th e in di vi du al us er an d is no t to be di ss em in at ed br oa dl y. 188 February–March 2015 ● American Psychologist ability of ovarian cancer cells to resist anoikis (and thus survive) when detached from the ECM, in both in vitro and animal models (Sood et al., 2010).”
BackgroundSelf-citationLinking Heart Failure to Cancer: Background Evidence and Research Perspectives
Bertero, E., Canepa, M., Maack, C., & Ameri, P. (2018) · Circulation · doi:10.1161/circulationaha.118.033603 · Cited by 178
Social influences on clinical outcomes of patients with ovarian cancer
Lutgendorf, S. K., De Geest, K., Bender, D., Ahmed, A., Goodheart, M. J., Dahmoush, L., Zimmerman, M. B., Penedo, F. J., Lucci, J. A., Ganjei-Azar, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.4411 · Cited by 177
“The sympathetic nervous system, one of the major stress response systems, has been shown to promote ovarian cancer growth in preclinical models via beta adrenergic stimulation of angiogenesis, invasion, anoikis, and other metastatic processes.(37-40) Similar processes have been observed in mammary cancer in vivo as we…”
BackgroundSelf-citationAdrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
Qiao, G., Chen, M., Bucsek, M. J., Repasky, E. A., & Hylander, B. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00164 · Cited by 168
Tang, J., Li, Z., Lu, L., & Cho, C. H. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.009 · Cited by 160
“[36] uncovered a different tumorigenic mechanism in the regulation of adrenergic system in ovarian tumour growth.”
BackgroundEng, J. W.-L., Reed, C. B., Kokolus, K. M., Pitoniak, R., Utley, A., Bucsek, M. J., Ma, W. W., Repasky, E. A., & Hylander, B. L. (2015) · Nature Communications · doi:10.1038/ncomms7426 · Cited by 157
Li, J., Yang, X.-M., Wang, Y.-H., Feng, M.-X., Liu, X.-J., Zhang, Y.-L., Huang, S., Wu, Z., Xue, F., Qin, W.-X., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.025 · Cited by 154
“Studies of ovarian cancer have demonstrated that NE/E may contribute to tumor progression by promoting angiogenesis [9].”
BackgroundResultImpact of beta blockers on epithelial ovarian cancer survival
Diaz, E. S., Karlan, B. Y., & Li, A. J. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.07.102 · Cited by 162
“Several preclinical studies have supported a relationship between chronic stress, neuroendocrine modulators, and tumor pathogenesis [9,10,16–22] Lutgendorf and colleagues determined that sympathetic nervous system stress mediators may directly influence angiogenesis and tumor growth, independent of the effects on the…”
BackgroundJi, Y., Chen, S., Xu, C., Li, L., & Xiang, B. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13388 · Cited by 160
Neuroendocrine influences on cancer progression
Armaiz-Pena, G. N., Cole, S. W., Lutgendorf, S. K., & Sood, A. K. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.005 · Cited by 145
“We found that NE and Epi can protect ovarian cancer cells from anoikis by inducing the activation of focal adhesion kinase (FAK) through an ADRB/ PKA/Src dependent pathway (Sood et al., 2010).”
BackgroundSelf-citationSustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction
Allen, J. K., Armaiz-Peña, G. N., Nagaraja, A. S., Sadaoui, N. C., Ortíz, T., Dood, R. L., Ozcan, M., Herder, D. M., Haemmerle, M., Gharpure, K. M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-16-1701 · Cited by 145
“To induce tumoral catecholamine levels, we used a well-characterized restraint stress model (4,6,7).”
Self-citationEpinephrine: A Short- and Long-Term Regulator of Stress and Development of Illness
Wong, D. L., Tai, T. C., Wong‐Faull, D. C., Claycomb, R., Meloni, E. G., Myers, K. M., Carlezon, W. A., & Květňanský, R. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9768-0 · Cited by 154
“Stress hormones are thought to modulate FAK, which, in turn, facilitates tumor formation (Sood et al. 2010).”
BackgroundGanz, P. A., Habel, L. A., Weltzien, E. K., Caan, B. J., & Cole, S. W. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1505-3 · Cited by 137
“Beta adrenergic signaling may also support the survival of disseminated carcinoma cells (anoikis) [47].”
BackgroundSelf-citationEvolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
Baker, J. G., Hill, S. J., & Summers, R. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.02.010 · Cited by 159
“Noradrenaline treatment causes increased pFAKY397 phosphorylation and decreased anoikis, which can be blocked by cell pretreatment with FAK siRNA [70].”
BackgroundInfluentialSignaling pathways in the development of infantile hemangioma
Ji, Y., Chen, S., Li, K., Li, L., Xu, C., & Xiang, B. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-13 · Cited by 145
“of EPAC leads to the Rap1A-mediated activation of Raf/MAPK signaling pathw demonstrated that β-adrenergic signaling can regulate multiple fundamental biological processes underlying the progression and metastasis of tumors, including the promotion of inflammation [72-74], angiogenesis [75-78], migration [79], invasion…”
BackgroundPopow, J., Arnhof, H., Bader, G., Berger, H., Ciulli, A., Covini, D., Dank, C., Gmaschitz, T., Greb, P., Karolyi-Özguer, J., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01826 · Cited by 138
Biobehavioral Influences on Cancer Progression
Costanzo, E. S., Sood, A. K., & Lutgendorf, S. K. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2010.09.001 · Cited by 126
Self-citationPropranolol Reduces Cancer Risk
Chang, P., Huang, W., Lin, C., Huang, T., Wu, Y., Chen, J.-H., & Kao, C. (2015) · Medicine · doi:10.1097/md.0000000000001097 · Cited by 134
Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment
Dai, Y., Zhang, X., Ou, Y., Zou, L., Zhang, D., Yang, Q., Qin, Y., Du, X., Li, W., Yuan, Z., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01183-4 · Cited by 137
Inbar, S., Neeman, E., Avraham, R., Benish, M., Rosenne, E., & Ben-Eliyahu, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019246 · Cited by 123
“system [6,7], and gastrointestinal tract [8,9].”
BackgroundDhabhar, F. S., Saul, A. N., Holmes, T. H., Daugherty, C., Neri, E., Tillie, J. M., Kusewitt, D., & Oberyszyn, T. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033069 · Cited by 119
“[106] through activation of focal adhesion kinase [107], and dysregulation or suppression of immune function (for review see: [30,99]).”
BackgroundSurgery-mediated tumor-promoting effects on the immune microenvironment
Cheng, X., Zhang, H., Hamad, A., Huang, H., & Tsung, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.01.006 · Cited by 134
The cancer-immune dialogue in the context of stress
Ma, Y., & Kroemer, G. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00949-8 · Cited by 131
“It can also activate SRC-dependent phosphorylation of the kinase FAK and render human ovarian cancer cells resistant to anoikis 262 .”
Zhou, S., Yi, T., Liu, R., Bian, C., Qi, X., He, X., Wang, K., Li, J., Zhao, X., Huang, C., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.017988 · Cited by 125
“established model of apoptosis resulting from loss of cell matrix interaction (29).”
BackgroundZhou, L., Li, Y., Li, X., Chen, G., Liang, H., Wu, Y., Tong, J., & Ouyang, W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501677 · Cited by 113
“CMI are primarily mediated through their specific binding to the b-adrenergic receptors (b-AR) of immune cells, which promote tumor survival, migration, and resistance to anoikis (19, 23).”
BackgroundFu, X., Shi, Y., Zhou, J., Peng, Y., Liu, W., Shi, G., Gao, Q., Wang, X., Song, K., Fan, J., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.012 · Cited by 117
Neeman, E., Zmora, O., & Ben-Eliyahu, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1087 · Cited by 114
“facilitate tumor angiogenesis, survival, migration, proliferation, and resistance to anoikis—effects that were all blocked by b-antagonists (5, 7, 10, 11, 13, 30, 31).”
Influence of stress on extracellular matrix and integrin biology
Jean, C., Gravelle, P., Fournié, J., & Laurent, G. (2011) · Oncogene · doi:10.1038/onc.2011.27 · Cited by 117
“More recently, this group has described that, in the same model, catecholamines accumulation resulted in FAK activation responsible for tumor progression (Sood et al., 2010).”
Calvani, M., Pelon, F., Comito, G., Taddei, M. L., Moretti, S., Innocenti, S., Nassini, R., Gerlini, G., Borgognoni, L., Bambi, F., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2652 · Cited by 121
“The three subtypes of β-ARs, β1, β2, and β3, are widely expressed in different tumors, such as those of the brain, lung, liver, kidney, adrenal gland, breast, ovary, prostate or lymphoid tissues [4–7].”
BackgroundTumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
Yin, M., Shen, J., Yu, S., Jing, F., Zhu, X., Zhao, J., Zhai, L., Sadhukhan, A., & Zhou, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s216355 · Cited by 111
“Norepinephrine and epinephrine prevent ovarian cancer cells from anoikis.(87,88) Inhibitor of c-Met and VEGFR-2, Foretinib (GSK1363089), can enhance anoikis and suppress ovarian cancer metastasis.”
BackgroundWard, K. K., Tancioni, I., Lawson, C., Miller, N. L. G., Jean, C., Chen, X. L., Uryu, S., Kim, J., Tarin, D., Stupack, D. G., et al. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9562-5 · Cited by 108
“implicated in promoting adrenergic receptor-stimulated ovarian carcinoma cell survival [19].”
Blackburn, E. H. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0195 · Cited by 103
“target was suggested by recent work showing the mechanistic link between adrenergic stress and focal adhesion kinase (FAK) activation (which protects cells from anoikis), supporting the potential of b-2 adrenergic receptor blockers to intercept metastasis (44).”
BackgroundArmaiz-Pena, G. N., Gonzalez-Villasana, V., Nagaraja, A. S., Rodriguez-Aguayo, C., Sadaoui, N. C., Stone, R. L., Matsuo, K., Dalton, H. J., Previs, R. A., Jennings, N. B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2887 · Cited by 104
“Sympathetic nervous system activity directly influences the pathogenesis of ovarian carcinoma by protecting tumor cells from anoikis [4], promoting tumor cell invasion [5–7] and increasing tumor-associated angiogenesis [1, 8].”
Self-citationRepurposing of approved cardiovascular drugs
Ishida, J., Konishi, M., Ebner, N., & Springer, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1031-5 · Cited by 101
“In human cancer cell lines, catecholamine-induced proliferation and migration were inhibited by NSBB [26, 27], and enhanced invasiveness [30] and activated FAK by catecholamine were completely blocked by propranolol in a mouse model of ovarian cancer [28].”
BackgroundInfluentialCancer cells become less deformable and more invasive with activation of β-adrenergic signaling
Kim, T.-H., Gill, N. K., Nyberg, K. D., Nguyen, A. V., Hohlbauch, S. V., Geisse, N. A., Nowell, C. J., Sloan, E. K., & Rowat, A. C. (2016) · Journal of Cell Science · doi:10.1242/jcs.194803 · Cited by 109
Focal adhesion kinase and endothelial cell apoptosis
Lü, Q., & Rounds, S. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.05.003 · Cited by 105
Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer
Eke, I., Zscheppang, K., Dickreuter, E., Hickmann, L., Mazzeo, E., Unger, K., Krause, M., & Cordes, N. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju419 · Cited by 110
Reeder, A., Attar, M., Nazario, L., Bathula, C., Zhang, A., Hochbaum, D., Roy, E., Cooper, K. L., Oesterreich, S., Davidson, N. E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.133 · Cited by 93
“All rights reserved 0007 – 0920/15 FULL PAPER Keywords: breast cancer; cortisol; epinephrine; stress; paclitaxel British Journal of Cancer (2015) 112, 1461–1470 | doi: 10.1038/bjc.2015.133 www.bjcancer.com |DOI:10.1038/bjc.2015.133 1461 Sood et al, 2010).”
InfluentialCatecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer
Shi, M., Liu, D., Duan, H., Han, C., Wei, B., Qian, L., Chen, C., Guo, L., Hu, M., Yu, M., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-269 · Cited by 93
“In several recent studies, stress related proteins and pathways were linked directly to the behavioral alteration of malignant cells [10-17].”
Backgroundβ2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion
Creed, S. J., Le, C. P., Hassan, M., Pon, C. K., Albold, S., Chan, K. T., Berginski, M. E., Huang, Z., Bear, J. E., Lane, J. R., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0655-3 · Cited by 105
“For example, norepinephrine was shown to protect cancer cells from anoikis by activating and relocalizing focal adhesion kinase [34].”
BackgroundChronic stress in solid tumor development: from mechanisms to interventions
Yan, J., Chen, Y., Luo, M., Hu, X., Li, H., Liu, Q., & Zou, Z. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00903-9 · Cited by 96
Meta-analysis of the effects of beta blocker on survival time in cancer patients
Choi, C. H., Song, T., Kim, T. H., Choi, J. K., Park, J., Yoon, A., Lee, Y.-Y., Kim, T., Bae, D., Lee, J., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1658-7 · Cited by 89
Role of stress in the pathogenesis of cancer (Review)
Lempesis, I. G., Georgakopoulou, V., Papalexis, P., Chrousos, G. P., & Spandidos, D. A. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5572 · Cited by 87
“…cell anoikis resistance, and cancer cell EMT, thus boosting malignant cell detach‑ ment, invasiveness and circulation survival (99,100,157,183, 186,188‑190 Perceived stress, depressive symptoms, or social isola‑ tion have been shown to be associated with the increased expression of…”
BackgroundCheng, Y., Gao, X., Li, X.-J., Cao, Q., Zhao, D., Zhou, J., Wu, H., Wang, Y., You, L., Yang, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0177-4 · Cited by 87
“Early studies have identified adrenergic dependent activation of FAK in ovarian cancer [34] and renal cell carcinoma [35].”
Backgroundβ-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis
Childers, W. K., Hollenbeak, C. S., & Cheriyath, P. (2015) · Clinical Breast Cancer · doi:10.1016/j.clbc.2015.07.001 · Cited by 86
Yamazaki, S., Miyoshi, N., Kawabata, K., Yasuda, M. T., & Shimoi, K. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.05.030 · Cited by 82
Substance P and norepinephrine modulate murine chondrocyte proliferation and apoptosis
Opolka, A., Straub, R. H., Pasoldt, A., Grifka, J. K., & Grässel, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33449 · Cited by 82
“Data from studies of ovarian cancer cells suggest that stress hormones such as NE may protect cells from anoikis by activating and modulating the focal adhesion kinase (44).”
BackgroundBarrera, I., & Spiegel, D. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864259 · Cited by 75
Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
Yu, L., Wang, M., Yang, Y., Xu, F., Zhang, X., Xie, F., Gao, L., & Li, X. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008696 · Cited by 74
Mo, C., Li, J., Yang, S.-X., Guo, H., Liu, Y., Luo, X.-Y., Wang, Y., Li, J., Li, J., & Zou, Q. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0970-z · Cited by 72
Common cardiovascular medications in cancer therapeutics
Vaklavas, C., Chatzizisis, Y. S., & Tsimberidou, A. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.009 · Cited by 68
Kang, F., Ma, W., Ma, X., Shao, Y., Yang, W., Chen, X. S., Li, L., & Wang, J. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.121327 · Cited by 69
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Nagaraja, A. S., Dood, R. L., Armaiz-Pena, G., Kang, Y., Wu, S. Y., Allen, J. K., Jennings, N. B., Mangala, L. S., Pradeep, S., Lyons, Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93076 · Cited by 63
Self-citationThe ZNF304-integrin axis protects against anoikis in cancer
Aslan, B., Monroig, P., Hsu, M.-C., Pena, G. A., Rodriguez-Aguayo, C., Gonzalez-Villasana, V., Rupaimoole, R., Nagaraja, A. S., Mangala, S., Han, H.-D., et al. (2015) · Nature Communications · doi:10.1038/ncomms8351 · Cited by 62
Self-citationBiobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes
Chang, A., Sloan, E. K., Antoni, M. H., Knight, J. M., Telles, R., & Lutgendorf, S. K. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221096081 · Cited by 64
Self-citationMind-Body Practices in Cancer Care
Chaoul, A., Milbury, K., Sood, A. K., Prinsloo, S., & Cohen, L. G. (2014) · Current Oncology Reports · doi:10.1007/s11912-014-0417-x · Cited by 70
Self-citationBrown, C. W., Brodsky, A. S., & Freiman, R. N. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0334 · Cited by 60
“Stress has also been shown to activate FAK and protect ovarian cancer cells from anoikis by hormonal regulation (32).”
BackgroundBastos, D. B., Sarafim-Silva, B. A. M., Sundefeld, M. L. M. M., Ribeiro, A., Brandão, J. D. P., Biasoli, É. R., Miyahara, G. I., Casarini, D. E., & Bernabé, D. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202515 · Cited by 64
Neuroendocrine Regulation of Tumor-Associated Immune Cells
Colón-Echevarria, C. B., Lamboy-Caraballo, R., Aquino-Acevedo, A. N., & Armaiz-Peña, G. N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01077 · Cited by 62
Beta-adrenergic blocking drugs in breast cancer: a perspective review
Barron, T. I., Sharp, L., & Visvanathan, K. (2012) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012439738 · Cited by 67
“Sood and colleagues also showed that the β-AR agonists epinephrine and norepinephrine protected ovarian tumour cells from anoikis and that this effect was inhibited by the β1/β2-nonselective antagonist propranolol [Sood et al. 2010].”
BackgroundMutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
Iwanicki, M., Chen, H., Iavarone, C., Zervantonakis, I. K., Muranen, T. E., Novak, M., Ince, T. A., Drapkin, R., & Brugge, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.86829 · Cited by 61
“have implicated increased matrix production in early FT cancers (66) and integrin-mediated signaling in sustaining survival of HGS-OvCa cells under detachment conditions (67, 68).”
Mechanisms of Ovarian Cancer Metastasis: Biochemical Pathways
Nakayama, K., Nakayama, N., Katagiri, H., & Miyazaki, K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911705 · Cited by 61
“Recently, Sood et al. reported that norepinephrine and epinephrine protect ovarian cancer cells from anoikis via a FAK-mediated signaling pathway that is initiated by ADRB2 and involves subsequent Src-associated phosphorylation of FAKY397 [31].”
BackgroundMinding the body: Psychotherapy and cancer survival
Spiegel, D. (2014) · British Journal of Health Psychology · doi:10.1111/bjhp.12061 · Cited by 53
Ramondetta, L. M., Hu, W. M., Thaker, P. H., Urbauer, D. L., Chisholm, G. B., Westin, S. N., Sun, Y., Ramirez, P. T., Fleming, N. D., Sahai, S. K., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.07.004 · Cited by 50
Self-citationNew Insights on the Nuclear Functions and Targeting of FAK in Cancer
Pomella, S., Cassandri, M., Braghini, M. R., Marampon, F., Alisi, A., & Rota, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041998 · Cited by 50
“Furthermore, CEP-37440 is a brain-penetrant drug [91].”
Focal Adhesion Kinase as a Potential Target in AML and MDS
Carter, B. Z., Mak, P. Y., Wang, X., Yang, H., Garcia‐Manero, G., Mak, D. H. F., Mu, H., Ruvolo, V. R., Qiu, Y., Coombes, K. R., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0719 · Cited by 48
“14.4E DVS-Fluidigm (6) p-AKT 159Tb M89-61 BD Biosciences (7) p-SRC(Tyr416) 164Dy D49G4 Cell Signaling Technology (8) p-STAT5(Y694) 150Nd 47 DVS-Fluidigm (9) p-STAT3(Y705) 158Gd 4/P-STAT3 DVS-Fluidigm (10) p-FLT3 174Yb 30D4 Cell Signaling Technology (11) FLT3 162Dy 4G8 BD Biosciences www.aacrjournals.org Mol Cancer The…”
Liu, H., Ma, L.-L., Li, C., Cao, B., Jiang, Y., Han, L., Xu, R., Lin, J., & Zhang, D. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101281 · Cited by 48
Self-citationStress, Metabolism and Cancer: Integrated Pathways Contributing to Immune Suppression
Repasky, E. A., Eng, J. W. ‐., & Hylander, B. L. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000107 · Cited by 49
“, anoikis.(72) Other studies show that the expression of vascular endothelial growth factor and matrix metalloproteinases is increased in response to adrenergic signaling.”
BackgroundJang, H.-I., Lim, S., Lee, Y.-Y., Kim, T., Choi, C. H., Lee, J., Kim, B., & Bae, D. (2017) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2017.60.2.170 · Cited by 46
“And the mechanisms for these changes may be through the increase in catecholamines; they are known to act directly on malignant cells, activating several processes that are critical for tumor metastatic activity, including tumor cell proliferation [16,17], extracellular matrix invasion capacity [16], resistance to apo…”
BackgroundKandala, P. K., & Srivastava, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351379 · Cited by 45
“Thus, ovarian cancer makes a very attractive and important model to study anoikis (22, 23).”
BackgroundThe Influence of Psychological Stress on the Initiation and Progression of Diabetes and Cancer
Afrisham, R., Paknejad, M., Soliemanifar, O., Sadegh-Nejadi, S., Meshkani, R., & Ashtary-Larky, D. (2019) · International Journal of Endocrinology and Metabolism · doi:10.5812/ijem.67400 · Cited by 44
“Therefore, this signal protects cancer cells from anoikis (59).”
BackgroundIsoprenaline induces epithelial–mesenchymal transition in gastric cancer cells
Lu, Y., Geng, Z., Sun, X., Li, Y., Fu, X., Zhao, X., & Wei, B. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2477-0 · Cited by 47
Falcinelli, M., Alhity, G., Baron, S., Mampay, M., Allen, M. C., Samuels, M. E., Jones, W., Cilibrasi, C., Flaherty, R. L., Giamas, G., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.02.011 · Cited by 49
“…Received 10 June 2022; Received in revised form 10 February 2023; Accepted 11 February 2023 Brain Behavior and Immunity 110 (2023) 1–12 angiogenesis, metastasis, and protection from anoikis (Chen, 2021; Jeong, 2022; Kim, 2016; Nagaraja, 2017; Sood, 2010; Sood, 2006).”
Zhang, H., Yang, Y., Cao, Y., & Guan, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116609 · Cited by 47
Cancer and Stress: Does It Make a Difference to the Patient When These Two Challenges Collide?
Iftikhar, A., Islam, M. R., Shepherd, S. D., Jones, S., & Ellis, I. (2021) · Cancers · doi:10.3390/cancers13020163 · Cited by 48
“Ovarian cancer cells showed resistance to anoikis, when exposed to epinephrine or norepinephrine [213].”
Background
Metadata
- Authors
- Sood, A. K., Armaiz-Pena, G. N., Halder, J., Nick, A. M., Stone, R. L., Hu, W., Carroll, A. R., Spannuth, W. A., Deavers, M. T., Allen, J. K., Han, L. Y., Kamat, A. A., Shahzad, M. M. K., McIntyre, B. W., Diaz-Montero, C. M., Jennings, N. B., Lin, Y. G., Merritt, W. M., DeGeest, K., Vivas-Mejia, P. E., Lopez-Berestein, G., Schaller, M. D., Cole, S. W., & Lutgendorf, S. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Iowa (US)
- West Virginia University (US)
- Corresponding author
- Sood, Anil K.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2010-05-03
- Volume
- 120
- Issue
- 5
- Pages
- 1515-1523
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2860925
- OpenAlex
- W2129041527
- Cited by
- 283
- References
- 58
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 17 · 2023: 14 · 2022: 22 · 2021: 21 · 2020: 19 · 2019: 19 · 2018: 12 · 2017: 13 · 2016: 18 · 2015: 24 · 2014: 18 · 2013: 14 · 2012: 24
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA083639, CA101642)
- U.S. Public Health Service (A152737)
- University of Texas MD Anderson Cancer Center (CA101642)
- National Cancer Institute (CA 109298, F31CA126474, R01CA110793, CA 110793, CA 101642, CA-104825, R01CA109298, R01CA104825, R01CA140933, P50CA083639, T32CA101642)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- ovarian cancer, anoikis, focal adhesion kinase, adrenergic signaling, norepinephrine, epinephrine, chronic stress, restraint stress, Src kinase, actin, tumor progression, cancer mortality, stress hormones
- MeSH terms
- Actins, Animals, Disease Models, Animal, Epinephrine, Female, Humans, Mice, Nude, Norepinephrine, Ovarian Neoplasms, Phosphorylation, Adrenergic Agents, Anoikis, Cell Line, Tumor, Cell Proliferation, Mice, Focal Adhesion Protein-Tyrosine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.